MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $87,000 | -85.9% | 1,450 | -89.2% | 0.02% | -84.6% |
| Q1 2016 | $616,000 | -4.8% | 13,400 | 0.0% | 0.10% | +10.6% |
| Q4 2015 | $647,000 | -66.5% | 13,400 | -70.5% | 0.09% | -63.7% |
| Q3 2015 | $1,930,000 | -80.1% | 45,400 | -46.6% | 0.26% | -77.1% |
| Q2 2015 | $9,707,000 | -24.8% | 85,000 | -15.0% | 1.13% | -23.4% |
| Q1 2015 | $12,907,000 | – | 100,000 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |